EMPLOYMENT AGREEMENTEmployment Agreement • July 7th, 2011 • Biozone Pharmaceuticals, Inc. • Services-business services, nec • New York
Contract Type FiledJuly 7th, 2011 Company Industry JurisdictionThis Agreement is made and entered into as of the 30th day of June, 2011 by and between BioZone Pharmaceuticals, Inc., a Nevada corporation with principal offices at 4400 Biscayne Boulevard, Miami, FL 33137 (together with its successors and assigns, "BioZone"), and Daniel Fisher (the "Executive").
BETWEEN AS SELLER AND BIOZONE PHARMACEUTICALS, INC. AS BUYER EQUALAN LLCLLC Membership Interest Purchase Agreement • July 7th, 2011 • Biozone Pharmaceuticals, Inc. • Services-business services, nec • New York
Contract Type FiledJuly 7th, 2011 Company Industry JurisdictionThis LLC Membership Interest Purchase Agreement (“Agreement”) is entered into on June 30, 2011, between __________, an individual with an address at ______________________________ (“Seller”) and Biozone Pharmacuticals, Inc., a Nevada corporation, with an address at 4400 Biscayne Boulevard, Miami, Florida 33137 (“Buyer”).
STOCK OPTION AGREEMENTStock Option Agreement • July 7th, 2011 • Biozone Pharmaceuticals, Inc. • Services-business services, nec • New York
Contract Type FiledJuly 7th, 2011 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT (the “Agreement”) is made and entered into, effective as of June 30, 2011 (the “Effective Date”), by and between Daniel Fisher, an individual with an address at 23 Marlee Road, Pleasant Hill, CA 94523 (the “Optionor”), and Opko Health, Inc., with an address at 4400 Biscayne Boulevard, Miami Florida 33137 (the “Optionee”).
LOCK-UP AGREEMENTLock-Up Agreement • July 7th, 2011 • Biozone Pharmaceuticals, Inc. • Services-business services, nec • New York
Contract Type FiledJuly 7th, 2011 Company Industry JurisdictionThe undersigned is, or is anticipated to be, a beneficial owner of shares of capital stock, or securities convertible into or exercisable or exchangeable for the capital stock (each, a “Company Security”) of Biozone Pharmaceuticals, Inc., a Nevada corporation (the “Company”). The undersigned understands that the Company is acquiring certain businesses (the “Target Companies”) in consideration for an aggregate purchase price of 21,000,000 shares (the “Shares”) of the Company’s common stock (the “Purchase”) from the undersigned.and other owners of the Target Companies. The undersigned understands that the Company will proceed with the Purchase in reliance on this Letter Agreement to be signed by each of the owners of the Target Companies.
AMENDMENT TO LICENSE AGREEMENTLicense Agreement • July 7th, 2011 • Biozone Pharmaceuticals, Inc. • Services-business services, nec
Contract Type FiledJuly 7th, 2011 Company IndustryThis Amendment ("Amendment'"). effective as of ________, 2011. modifies the terms of the License Agreement ("Agreement") between BioZone Laboratories. Inc. and BetaZone Laboratories LLC dated November 7. 2006.
STOCK PURCHASE AGREEMENT BETWEEN AS SELLER AND BIOZONE PHARMACEUTICALS, INC. AS BUYER BIOZONE LABORATORIES, INC.Stock Purchase Agreement • July 7th, 2011 • Biozone Pharmaceuticals, Inc. • Services-business services, nec • New York
Contract Type FiledJuly 7th, 2011 Company Industry JurisdictionThis Stock Purchase Agreement (“Agreement”) is entered into on June 30, 2011, between __________, an individual with an address at ______________________________ ____________________________ (“Seller”) and Biozone Pharmacuticals, Inc., a Nevada corporation, with an address at 4400 Biscayne Boulevard, Miami, Florida 33137 (“Buyer”).
SECOND AMENDMENT TO LICENSE AGREEMENT BETWEEN BIOZONE LABORATORIES, INC AND BETAZONE LABORATORIES, LLCLicense Agreement • July 7th, 2011 • Biozone Pharmaceuticals, Inc. • Services-business services, nec
Contract Type FiledJuly 7th, 2011 Company IndustryThis Second Amendment (the “Second Amendment”), effective as of June 29, 2011, modifies the terms of the License Agreement (the “License”) between BioZone Laboratories, Inc. (“BioZone Labs”) and BetaZone Laboratories, LLC (‘BetaZone Labs or Licensee”) dated as of November 7, 2006 as modified by the Amendment to the License Agreement between BioZone Pharmaceutical, Inc. (“BPI”) and BetaZone Labs (the “First Amendment”) effective as of April [ ], 2011. All terms used herein shall have the definition applied to such terms in the License and the First Amendment.
LICENSE AGREEMENTLicense Agreement • July 7th, 2011 • Biozone Pharmaceuticals, Inc. • Services-business services, nec • California
Contract Type FiledJuly 7th, 2011 Company Industry JurisdictionThis License Agreement ("Agreement"), made this 07 day of November 2006,("Effective Date"), between, BioZone Laboratories INC, or its assigns, having its principal place of business at 580 Garcia Ave. Pittsburg, CA 94565 a corporation existing under the laws of the State of California ("Licensor"), and BetaZone Laboratories LLC, having its principal place of business at 1820 North Corporate Blvd. Suite 303 Weston, Florida 33327 United States a corporation existing under the laws of the State of Florida, or its assigns ("Licensee").